Thrombopoietin increases platelet adhesion under flow and decreases rolling

Area of Science:

• Hematology
• Platelet Biology
• Hemostasis and Thrombosis

Background:

• Thrombopoietin (TPO) is a key regulator of platelet production and function.
• At high concentrations (>100 ng/ml), TPO activates platelet aggregation and secretion.
• Lower TPO concentrations (0.01-1 ng/ml) are known to sensitize platelets to other agonists.

Purpose of the Study:

• To investigate the effect of low-dose TPO on platelet adhesion under shear conditions.
• To elucidate the mechanism by which TPO influences platelet adhesion to specific substrates.

Main Methods:

• Perfusion chamber studies using whole blood and reconstituted blood components.
• Assessing platelet adhesion to fibrinogen, fibronectin, and von Willebrand Factor (VWF) under varying shear rates (300-1000/s).
• Investigating the role of cyclooxygenase and thromboxane A2 pathways using inhibitors (indomethacin, SQ30741) and an analogue (U46619).

Main Results:

• Low-dose TPO (0.01-1 ng/ml) significantly increased platelet adhesion to VWF, fibrinogen, and fibronectin, but not collagen.
• This enhanced adhesion occurred at physiological shear rates (300/s and 800/s).
• The TPO-induced increase in adhesion was abolished by indomethacin and SQ30741, and mimicked by U46619, indicating thromboxane A2 involvement.
• TPO reduced the rolling phase of platelets on VWF, suggesting a role in firm platelet attachment.

Conclusions:

• Low-dose TPO potentiates platelet adhesion to ligands like VWF, fibrinogen, and fibronectin.
• The mechanism involves the thromboxane A2 pathway, suggesting TPO enhances alphaIIbbeta3 integrin activation.
• TPO may increase the ligand affinity of alphaIIbbeta3, promoting firm platelet attachment.